These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7515633)

  • 1. On the other hand: the stereoselectivity of drug action at ion channels.
    Triggle DJ
    Chirality; 1994; 6(2):58-62. PubMed ID: 7515633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral aspects of drug action at ion channels: a commentary on the stereoselectivity of drug actions at voltage-gated ion channels with particular reference to verapamil actions at the Ca2+ channel.
    Kwon YW; Triggle DJ
    Chirality; 1991; 3(5):393-404. PubMed ID: 1721828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
    Catterall WA
    Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of membrane lipids on ion channel structure and function.
    Tillman TS; Cascio M
    Cell Biochem Biophys; 2003; 38(2):161-90. PubMed ID: 12777713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroreceptors and ion channels as the basis for drug action: past, present, and future.
    Narahashi T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):1-26. PubMed ID: 10871290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phasic activation and state-dependent inhibition: an explicit solution for a three-state ion channel system.
    Uteshev VV; Pennefather PS
    J Theor Biol; 1996 Jul; 181(1):11-23. PubMed ID: 8796187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
    Grauert M; Rho JM; Subramaniam S; Rogawski MA
    J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mercurials on ligand- and voltage-gated ion channels: a review.
    Sirois JE; Atchison WD
    Neurotoxicology; 1996; 17(1):63-84. PubMed ID: 8784819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of neurotoxins acting on the inactivation of voltage-gated sodium channels].
    Benoit E
    C R Seances Soc Biol Fil; 1998; 192(3):409-36. PubMed ID: 9759381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective interactions between local anesthetics and ion channels.
    Valenzuela C; Moreno C; de la Cruz A; Macías Á; Prieto Á; González T
    Chirality; 2012 Nov; 24(11):944-50. PubMed ID: 22674834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
    Krishek BJ; Moss SJ; Smart TG
    Mol Pharmacol; 1996 Mar; 49(3):494-504. PubMed ID: 8643089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor and voltage-operated ion channels in the central nervous system.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 1995; 47(3):253-64. PubMed ID: 8714758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of recombinant Ca2+ channels by benzothiazepines and phenylalkylamines: class-specific pharmacology and underlying molecular determinants.
    Cai D; Mulle JG; Yue DT
    Mol Pharmacol; 1997 May; 51(5):872-81. PubMed ID: 9145926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion channels as pharmacologic receptors: the chirality of drug interactions.
    Triggle DJ
    Chirality; 1996; 8(1):35-8. PubMed ID: 8845280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.
    Chen HS; Lipton SA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutations at L1280 in Nav1.4 channel D3-S6 modulate binding affinity and stereoselectivity of bupivacaine enantiomers.
    Nau C; Wang SY; Wang GK
    Mol Pharmacol; 2003 Jun; 63(6):1398-406. PubMed ID: 12761351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markov modeling of allosteric drug effects on ion channels, with particular reference to neuronal nicotinic acetylcholine receptors.
    Madsen BW; Yeo GF
    Arch Biochem Biophys; 2000 Jan; 373(2):429-34. PubMed ID: 10620368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
    Oz M
    Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.